Christopher Bunka's Insider Trades & SAST Disclosures

Christopher Bunka's most recent trade in Lexaria Bioscience Corp was a trade of 11,000 Stock Options done . Disclosure was reported to the exchange on May 15, 2025.

Share

Note

This is a custom search result for pattern Christopher Bunka.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Lexaria Bioscience Corp	Christopher Bunka	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2025	11,000	184,834	-		-	Stock Options
Lexaria Bioscience Corp	Christopher Bunka	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jan 2025	100,000	373,543	-		0	Restricted Stock Award
Lexaria Bioscience Corp	Christopher Bunka	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Apr 2024	49,500	180,501	-		-	Stock Options
Lexaria Bioscience Corp	Christopher Bunka	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.99 per share.	12 Oct 2022	21,900	237,812	-	2.0	43,537	common shares
Lexaria Bioscience Corp	Christopher Bunka	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 2.10 per share.	12 Oct 2022	16,600	254,412	-	2.1	34,860	common shares
Lexaria Bioscience Corp	Christopher Bunka	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Aug 2022	30,000	101,001	-		-	Stock Options
Lexaria Bioscience Corp	Christopher Bunka	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Sep 2021	15,000	71,001	-		-	Stock Options
Lexaria Bioscience Corp	Christopher Bunka	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2021	23,334	56,001	-		-	Stock Options
Lexaria Bioscience Corp	Christopher Bunka	Director, CEO	Other type of transaction at price $ 0.00 per share.	07 May 2021	23,334	32,667	-		-	Stock Options
Lexaria Bioscience Corp	Christopher Bunka	Director, CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Apr 2021	26,000	56,001	-		-	Stock Options

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades